Inc., USA, has announced the launch of Clindamycin Phosphate Foam, 1%, a product that is bioequivalent and therapeutically equivalent to Evoclin® Foam, 1%, a product of Mylan (NASDAQ:VTRS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback